NCT02198326View on ClinicalTrials.gov

Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

August 31, 1999

Conditions
Healthy
Interventions
DRUG

BIBN 4096 BS- in single rising doses

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY